3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Mesenchymal Precursor Cells (MPCs): new trials by email Literature Review of Mesenchymal Precursor Cells (MPCs) trials Research Report on Mesenchymal Precursor Cells (MPCs)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy Mesenchymal Precursor Cells (MPCs) - Diabetic Nephropathy, Type 2 Diabetes | Phase 1 / Phase 2 | Completed | Mesoblast, Ltd. | 30 | 2013-07-01 | 2016-10-14 |
| Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes Mesenchymal Precursor Cells (MPCs) - Type 2 Diabetes | Phase 1 / Phase 2 | Completed | Mesoblast, Ltd. | 61 | 2012-04-01 | 2020-06-02 |
| A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure Mesenchymal Precursor Cells (MPCs), standard-of-care treatment with mock mapping and injection procedures. - Heart Failure | Phase 2 | Completed | Mesoblast, Ltd. | 60 | 2008-08-01 | 2020-03-11 |
Diabetes Mellitus, Type 2 (2) · Diabetic Nephropathies (1) · Heart Failure (1) · Metabolic Diseases (1) · Renal Insufficiency, Chronic (1)
Mesoblast, Ltd. (3)
United States (2) · Australia (1)
K Segal, PhD (2) · Emerson Perin, MD (1)